Evidence map›Paper›PMID 38492196›Full record

ArticleInfection2024

Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne-Bonn region: a retrospective cohort study.

Isabelle Suárez, Dominic Rauschning, Cora Schüller, Anna Hagemeier, Melanie Stecher, Clara Lehmann, Philipp Schommers, Stefan Schlabe, Jörg-Janne Vehreschild, Carolin Koll and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Infection, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Isabelle Suárez *Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Dominic Rauschning *Department I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Cora SchüllerDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Anna HagemeierMedical Faculty and University Hospital Cologne, Institute of Medical Statistics and Computational Biology, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0002-8795-7352
Melanie StecherDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Clara LehmannDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Philipp SchommersDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Stefan SchlabeDepartment of Medicine I, University Hospital Bonn, Bonn, Germany.
Jörg-Janne VehreschildDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Carolin KollDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Carolynne Schwarze-ZanderGerman Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany.
Jan-Christian WasmuthGerman Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany.
Angela KlingmüllerDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Jürgen Kurt RockstrohGerman Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany.
Gerd FätkenheuerDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Christoph BoeseckeGerman Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne/Bonn, Germany.
Jan RybnikerDepartment I of Internal Medicine, Medical Faculty and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. jan.rybniker@uk-koeln.de.
University of Cologne · DEUniversity Hospital Bonn · DEGoethe University Frankfurt · DE

Funding

Deutsche Forschungsgemeinschaft SFB 1403Deutsches Zentrum für Infektionsforschung TI 07.001_SUAREZ_00Deutsches Zentrum für Infektionsforschung TTU 02.806German Federal Ministry of Education and Research (BMBF) 01KI1017Innovative Medicines Initiative 2 Joint Undertaking No. 853989 (ERA4TB)
6 · The paper itself

Abstract

purposeThe risk of developing active tuberculosis (TB) is considerably increased in people living with HIV/AIDS (PLWH). However, incidence of HIV/TB coinfection is difficult to assess as surveillance data are lacking in many countries. Here, we aimed to perform a quantitative analysis of HIV/TB coinfections within the Cologne/Bonn HIV cohort and to determine risk factors for active TB.

methodsWe systematically evaluated data of patients with HIV/TB coinfection between 2006 and 2017. In this retrospective analysis, we compared HIV/TB-coinfected patients with a cohort of HIV-positive patients. The incidence density rate (IDR) was calculated for active TB cases at different time points.

resultsDuring 2006-2017, 60 out of 4673 PLWH were diagnosed with active TB. Overall IDR was 0.181 cases/100 patient-years and ranged from 0.266 in 2006-2009 to 0.133 in 2014-2017. Patients originating from Sub-Saharan Africa had a significantly (p < 0.001) higher IDR (0.694/100 patient-years of observation, 95% CI [0.435-1.050]) in comparison to patients of German origin (0.053/100 patient-years of observation, 95% CI [0.028-0.091]). In terms of TB-free survival, individuals originating from countries with a TB incidence higher than 10/100,000 exhibited a markedly reduced TB-free survival compared to those originating from regions with lower incidence (p < 0.001). In 22 patients, TB and HIV infection were diagnosed simultaneously.

conclusionOverall, we observed a decline in the incidence density rate (IDR) of HIV/TB coinfections between 2006 and 2017. Patients originating from regions with high incidence bear a higher risk of falling ill with active TB. For PLWH born in Germany, the observed risk of active TB appears to be lower compared to other groups within the cohort. These findings should be considered when developing TB containment and screening strategies for PLWH in low-incidence countries.

Indexed as

CoinfectionHIV InfectionsTuberculosisAdultCohort StudiesFemaleGermanyHumansIncidenceMaleMiddle AgedRetrospective StudiesRisk FactorsYoung AdultAntiretroviral therapyGermanyHIVImmigrantsTB low-burden countryTuberculosis

Identifiers

PMID38492196
PMCPMC11289312
OpenAlexW4392883538

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.